Characterization of PTPRG in knockdown and phosphatase-inactive mutant mice and substrate trapping analysis of PTPRG in mammalian cells

Autor: Nianhua Xu, Sean Hu, Kenneth A. Platt, Wandong Zhang, Emily B. Cullinan, Thomas H. Lanthorn, David T. Tran, Vladimir M. Pogorelov, Katerina V. Savelieva, Kevin B. Baker, Indrani Rajan
Rok vydání: 2012
Předmět:
Male
Genetic Screens
Mouse
Mutant
lcsh:Medicine
Protein tyrosine phosphatase
Biochemistry
Substrate Specificity
Gene Knockout Techniques
Mice
Behavioral Neuroscience
Gene Order
Drug Discovery
Molecular Cell Biology
Membrane Receptor Signaling
Tyrosine
Phosphorylation
lcsh:Science
Mice
Knockout

Gene knockdown
Multidisciplinary
Receptor-Like Protein Tyrosine Phosphatases
Class 5

Animal Models
Recombinant Proteins
Enzymes
Phenotype
Gene Targeting
Female
Research Article
Biotechnology
Signal Transduction
Phosphatase
Physical Exertion
Mutagenesis (molecular biology technique)
Biology
Motor Activity
Molecular Genetics
Model Organisms
Genetic Mutation
Genetics
Animals
Humans
Enzyme Kinetics
lcsh:R
Wild type
Proteins
Molecular biology
Transmembrane Proteins
HEK293 Cells
Mutagenesis
Mutation
Genetics of Disease
lcsh:Q
Gene Function
Animal Genetics
Neuroscience
Zdroj: PLoS ONE
PLoS ONE, Vol 7, Iss 9, p e45500 (2012)
ISSN: 1932-6203
Popis: Receptor tyrosine phosphatase gamma (PTPRG, or RPTPγ) is a mammalian receptor-like tyrosine phosphatase which is highly expressed in the nervous system as well as other tissues. Its function and biochemical characteristics remain largely unknown. We created a knockdown (KD) line of this gene in mouse by retroviral insertion that led to 98–99% reduction of RPTPγ gene expression. The knockdown mice displayed antidepressive-like behaviors in the tail-suspension test, confirming observations by Lamprianou et al. 2006. We investigated this phenotype in detail using multiple behavioral assays. To see if the antidepressive-like phenotype was due to the loss of phosphatase activity, we made a knock-in (KI) mouse in which a mutant, RPTPγ C1060S, replaced the wild type. We showed that human wild type RPTPγ protein, expressed and purified, demonstrated tyrosine phosphatase activity, and that the RPTPγ C1060S mutant was completely inactive. Phenotypic analysis showed that the KI mice also displayed some antidepressive-like phenotype. These results lead to a hypothesis that an RPTPγ inhibitor could be a potential treatment for human depressive disorders. In an effort to identify a natural substrate of RPTPγ for use in an assay for identifying inhibitors, “substrate trapping” mutants (C1060S, or D1028A) were studied in binding assays. Expressed in HEK293 cells, these mutant RPTPγs retained a phosphorylated tyrosine residue, whereas similarly expressed wild type RPTPγ did not. This suggested that wild type RPTPγ might auto-dephosphorylate which was confirmed by an in vitro dephosphorylation experiment. Using truncation and mutagenesis studies, we mapped the auto-dephosphorylation to the Y1307 residue in the D2 domain. This novel discovery provides a potential natural substrate peptide for drug screening assays, and also reveals a potential functional regulatory site for RPTPγ. Additional investigation of RPTPγ activity and regulation may lead to a better understanding of the biochemical underpinnings of human depression.
Databáze: OpenAIRE